Harvard-trained infectious disease doctor Bill Rodriguez proves that you can do well and also do good.
Working with colleagues from Massachusetts General Hospital, and several Boston-area investors, Rodriguez has raised $2.8 million in funding for a new start-up he founded. Cambridge-based Daktari (``doctor'' in Swahili) Diagnostics will develop affordable, point-of-care diagnostic tests primarily for people in poor countries living with HIV, the AIDS virus. Daktari's first product is an inexpensive, hand-held device that counts CD4 cells, providing a critical test of the immune system. Establishing a person's CD4 count is important in determining when to start antiretroviral treatment; current technology is far too cumbersome and expensive for most rural clinics in Africa and developing countries.
Read more about Daktari's unique business model here.
This program aired on September 8, 2009. The audio for this program is not available.